Levofloxacin-related seizure activity in a patient with Alzheimer's disease: Assessment of potential risk factors

被引:12
作者
Bird, SB [1 ]
Orr, PG
Mazzola, JL
Brush, DE
Boyer, EW
机构
[1] Univ Massachusetts, Sch Med, Dept Emergency Med, Div Toxicol, Worcester, MA 01605 USA
[2] Massachusetts Coll Pharm & Hlth Sci, Sch Pharm, Worcester, MA USA
[3] Childrens Hosp, Div Med Toxicol, Boston, MA 02115 USA
关键词
D O I
10.1097/01.jcp.0000162811.15066.8e
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:287 / 288
页数:2
相关论文
共 20 条
[11]  
Kushner JM, 2001, ANN PHARMACOTHER, V35, P1194
[12]   Fluoroquinolone toxicity profiles: A review focusing on newer agents [J].
Lipsky, BA ;
Baker, CA .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) :352-364
[13]   Levofloxacin and sparfloxacin: New quinolone antibiotics [J].
Martin, SJ ;
Meyer, JM ;
Chuck, SK ;
Jung, R ;
Messick, CR ;
Pendland, SL .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (03) :320-336
[14]   CITALOPRAM - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN DEPRESSIVE-ILLNESS [J].
MILNE, RJ ;
GOA, KL .
DRUGS, 1991, 41 (03) :450-477
[15]  
RARITAN NJ, 2003, LEVAQUIN LEVOFLAXACI
[16]   Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model [J].
Schmuck, G ;
Schürmann, A ;
Schlüter, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1831-1836
[17]  
SQUIRES RF, 1993, MOL PHARMACOL, V43, P795
[18]   INHIBITORY EFFECTS OF QUINOLONE ANTIBACTERIAL AGENTS ON GAMMA-AMINOBUTYRIC ACID BINDING TO RECEPTOR-SITES IN RAT-BRAIN MEMBRANES [J].
TSUJI, A ;
SATO, H ;
KUME, Y ;
TAMAI, I ;
OKEZAKI, E ;
NAGATA, O ;
KATO, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (02) :190-194
[19]   THE PROCONVULSIVE ACTIVITY OF QUINOLONE ANTIBIOTICS IN AN ANIMAL-MODEL [J].
WILLIAMS, PD ;
HELTON, DR .
TOXICOLOGY LETTERS, 1991, 58 (01) :23-28
[20]   Latest industry information on the safety profile of levofloxacin in Japan [J].
Yagawa, K .
CHEMOTHERAPY, 2001, 47 :38-43